The best solution is to prevent healthcare-associated infections before they can take their toll. However, since not all healthcare-associated infections are preventable, and many patients are admitted into hospitals with infections already manifesting, faster diagnosis and earlier appropriate treatment are essential to ensure optimal patient outcomes.
Preventing the spread of drug-resistant bacteria is essential to any infection prevention and control program. Active surveillance testing for MRSA and VRE colonization is a proven, essential intervention strategy for preventing MDRO-associated HAIs, and is recommended by CDC, SHEA, APIC and IHI.*
 |
BD MAX™ System
The BD MAX™ System, previously known as the HandyLab Jaguar System, represents the next generation in fully-automated testing for molecular diagnostics. Enabling walk away and on-demand workflow, the system fully automates cell lysis, nucleic acid extraction, PCR set-up, amplification and detection. The BD MAX™ System provides maximum testing flexibility, efficiency and scalability for molecular testing in laboratories.
More information on BD MAX™ System
|
 |
BD GeneOhm™ Cdiff Assay
The BD GeneOhm™ Cdiff assay is the first diagnostic method to combine speed, sensitivity and specificity in a single method and provides definitive results that can be trusted for the detection of the C. difficile toxin B gene (tcdB) direct from patient samples. Quickly reaching a definitive diagnosis can ensure that CDI patients get the proper treatment without delay(1). CDI patients can be placed in isolation sooner to reduce transmission and prevent outbreaks(2). Definitive results can help reduce inappropriate antimicrobial use in negative patients, which is consistent with antimicrobial stewardship guidelines(3).
1 Kuijpers et al., Clin Microbiol Infect 2006;12(Suppl. 6):2-18
2 McFarland et al., AJIC 2007;35:237-253
3 Dellit et al., Clinical Infectious Diseases 2007; 44:159-77
More information on BD GeneOhm™ Cdiff Assay
|
 |
BD GeneOhm™ MRSA ACP Assay
The BD GeneOhm™ MRSA ACP rapid molecular assay simplifies assay workflow by incorporating enzymatic achromopeptidase (ACP) lysis technology which results in fewer steps and less technologist hands-on time.
More information on BD GeneOhm™ MRSA ACP Assay
|
 |
BBL™ CHROMagar® MRSA II
BBL™ CHROMagar® MRSA II delivers enhanced performance and flexible workflow for the detection of MRSA from nasal specimens.**
More information on BD BBL™ CHROMagar™ MRSA (US)
|
 |
BD BBL™ CultureSwab™ Devices
BD BBL™ CultureSwab™ devices are sterile ready-to-use systems intended for the collection, transport and preservation of clinical specimens for bacteriological examination.
More information on BD BBL™ CultureSwab™ (US) |
Innovative, single-use specimen collection systems designed to help reduce pathogen exposure.
|
BD Vacutainer® Push Button Blood Collection Sets
The BD Vacutainer® Push Button Blood Collection Set offers split-second protection for that single moment that could potentially change your life. The push-button safety mechanism instantly helps protect you against needlestick injury. It is also offered with a pre-attached holder for added convenience and OSHA single-use holder compliance.
More information on the BD Vacutainer® Push Button Blood Collection Sets (US)
|
|
BD Vacutainer® Eclipse™ Blood Collection Needles
BD Vacutainer® Eclipse™ Blood Collection Needles offer a simple, effective way to collect blood and help reduce the possibility of accidental needlesticks with one-handed activation technique. Also offered with pre-attached holders for added convenience and OSHA single-use holder compliance.
More information on BD Vacutainer® Eclipse™ Blood Collection Needles (US)
|
|
BD Vacutainer® Stretch Latex-Free Tourniquet
The BD Vacutainer® Stretch Latex-Free Tourniquet is ideal for practitioners and facilities that want to eliminate latex from their healthcare products. This latex-free tourniquet will not cause a latex-induced allergic reaction in latex-sensitive patients or employees. Convenient packaging allows for easy, one-at-a-time dispensing of tourniquets - encouraging a single-use policy that helps reduce the danger of cross-contamination between patients and healthcare workers.
More information on BD Vacutainer® Stretch Latex-Free Tourniquet (US)
|
Catheter-related bloodstream infections (CRBSIs) are a major concern, as the reported 80,000 CRBSIs annually in the U.S. have an estimated mortality rate of 12–25 percent. BD has a long-standing leadership role in intravenous (IV) therapy and closed IV access systems designed to help prevent bloodstream infections.
|
BD Nexiva™ Closed IV Catheter System
The BD Nexiva™ Closed IV Catheter System is designed to lower the risk of patient infection by reducing the potential for fluid pathway contamination.
|
|
BD PosiFlush™ Pre-Filled Syringes
For optimal clinical outcomes, there's just one choice for your saline and heparin flush syringes: BD PosiFlush Pre-Filled Saline and Heparin Syringes. The uniquely designed BD PosiFlush Syringe provides all the quality and outcomes you've come to expect from BD.
More information on BD PosiFlush™ Pre-Filled Syringes (US)
|
|
BD split septum IV access devices
BD split septum IV access devices were all engineered with infection control and prevention of HAIs in mind.
More information on:
BD Q-Syte™ Luer Access Split-Septum (US)
Interlink® Needleless IV Access Devices (US)
|
Faster Diagnosis for Earlier Appropriate Antibiotic Treatment - It makes sense that the earlier a patient presenting with symptoms of an infection is put on the proper antibiotic, the better the outcome.* BD is committed to enabling earlier actionable diagnostic information.
|
BD BACTEC™ Instrumented Blood Culture Systems
The BACTEC™ 9000 series blood culturing instruments used with patented resin-containing media have shown higher rates of organism recovery, allowing for proper diagnosis and treatment of bloodstream infections.*
More information on BD BACTEC™ Instrumented Blood Culture Systems (US)
|
|
BD GeneOhm™ StaphSR Assay
The BD GeneOhm™ StaphSR assay provides simultaneous identification of both MRSA and Staphylococcus aureus from a positive BD BACTEC blood culture. The two-hour diagnostic result will allow for earlier initiation of appropriate antimicrobial therapy.
More information on BD GeneOhm™ StaphSR (US)
|
|
BD Phoenix™ Automated Microbiology System
The BD Phoenix™ Automated Microbiology System , with its unique technology for susceptibility testing, provides high accuracy combined with rapid time to result. Because MRSA, VRE and Extended Spectrum beta-lactamase (ESBL) are the most important resistance markers linked to HAIs, the performance of the laboratory’s ID-AST system to detect these mechanisms is critical.
More information on the BD Phoenix™ Automated Microbiology System (US)
|
|
BD EpiCenter™ Microbiology Data Management System
The BD EpiCenter™ Microbiology Data Management System provides unique software that enables microbiologists, infection control professionals, pharmacists and physicians to work in a collaborative, integrated fashion to optimally manage Healthcare-Associated Infections (HAIs) in their facilities. The software is compatible with the hospital’s existing Microsoft Windows™ computer network, providing simultaneous access to all connected staff. BD EpiCenter™ delivers healthcare professionals with a library of ready-to-use epidemiology reports designed to discover and monitor HAI outbreaks and trends. The system deploys a user-defined “Pro-Active” alerting system for the instant communication of sentinel events such as HAIs and antimicrobial-resistance marker detection.
More information on the BD EpiCenter™ Data Management System (US)
|
|
BD Protect™ Infection Prevention
BD Protect™ Infection Prevention enables real-time infection surveillance by integrating patient data from admission, surgical, microbiology laboratory, pharmacy and other hospital systems.
- More Time to Help Reduce HAIs
Alerts and reports inform you of potential HAI-related events as they unfold, so you can focus on improving processes and outcomes.
- Support Compliance with National Patient Safety Goals
BD Protect™ provides new MDRO alerts and evidence-based surveillance for surgical site and central line infections.
- HAI Mandatory Reporting to NHSN
BD Protect™ transfers, transforms and validates patient data for CDC readiness, and creates and NHSN import file to reduce NHSN manual data entry.
- Extensive Data Analysis
NHSN benchmarking, control charts and statistical tools provide unlimited analysis of HAI-related data.
More information on BD Protect™ Infection Prevention (US)
|
|
The BD Vacutainer® Urine C&S Preservative Plus Plastic Tube
with its unique preservative formula, doesn't allow bacteria to overgrow, helping the clinician in identifying the pathogen of a urinary tract infection sooner. Once the pathogen is identified, treatment can be initiated quickly.
More information on the BD Vacutainer® Urine C&S Preservative Plus Plastic Tube (US)
|
|
